Chemotherapy-Induced Oral Mucositis Market: How Is Low-Level Laser...

adicionou um novo artigo Health

2026-06-01 09:13:58 -

Chemotherapy-Induced Oral Mucositis Market: How Is Low-Level Laser Therapy Creating Evidence-Based Clinical Adoption?

Low-level laser therapy's evidence-based CIOM clinical adoption — the growing clinical evidence base for photobiomodulation therapy (PBMT) — formerly termed low-level laser therapy (LLLT) — in both prevention and treatment of chemotherapy-induced and radiation-induced oral mucositis — with multiple randomized controlled trials, systematic reviews, and meta-analyses...

0 Comentários 0 Compartilhamentos 187 Visualizações 0 Anterior